BECTON, DICKINSON AND COMPANY Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves
BECTON, DICKINSON AND COMPANY (BDX) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves of $180.00 million as of 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves · last filed 2025-11-25
- 2025-09-30: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves $180.00M.
- 2024-09-30: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves $261.00M.
- 2023-09-30: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves $362.00M.
- 2022-09-30: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves $133.00M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves |
|---|---|
| 2025-09-30 | $180.00M 10-K · filed 2025-11-25 |
| 2024-09-30 | $261.00M 10-K · filed 2025-11-25 |
| 2023-09-30 | $362.00M 10-K · filed 2024-11-27 |
| 2022-09-30 | $133.00M 10-K · filed 2023-11-21 |
| 2021-09-30 | $191.00M 10-K · filed 2022-11-22 |
| 2020-09-30 | $241.00M 10-K · filed 2021-11-24 |
| 2019-09-30 | $182.00M 10-K · filed 2020-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |